Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine

American Journal of Veterinary Research

Volumn 71, Issue 12, 2010, Pages 1468-1474

  McCleary Wheeler, Angela L ^a   Williams, Laurel E ^a   Hess, Paul R ^a   Suter, Steven E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL DOG; FEMALE; IN VITRO STUDY; LOWER URINARY TRACT SYMPTOM; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRANSITIONAL CELL CARCINOMA; URINALYSIS;

ANIMALS; CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; DOG DISEASES; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME STABILITY; FIBROBLASTS; LUNG; POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE;

ANIMALIA; CANIS FAMILIARIS;

EID: 78649712482     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.12.1468     Document Type: Article

References (50)

1. Maxie MG, Prescott JF. The urinary system. In: Jubb KVF, Kennedy PC, Palmer N, eds. Pathology of domestic animals. 4th ed. San Diego: Academic Press, 2003;536-538.
2. Glickman LT, Raghavan M, Knapp DW, et al. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 2004;224:1290-1297. (Pubitemid 38490027)
3. Norris AM, Laing EJ, Vallie VE, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992;6:145-153.
4. Nyland TG, Wallack ST, Wisner ER. Needle-tract implantation following us-guided fine-needle aspiration biopsy of transitional cell carcinoma of the bladder, urethra, and prostate. Vet Radiol Ultrasound 2002;43:50-53.
5. Chao D, Freedland SJ, Pantuck AJ, et al. Bladder cancer 2000: moledular markers for the diagnosis of transitional cell carcinoma. Rev Urol 2001;3:85-93.
6. Henry CJ, Tyler JW, McEntee MC, et al. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Am J Vet Res 2003;64:1017-1020.
7. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
8. Huffman KE, Levene SD, Tesmer VM, et al. Telomere shortening is proportional to the size of the G-rich telomeric 3′-overhang. J Biol Chem 2000;275:19719-19722.
9. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
10. Harley CB. Telomere loss: mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
11. Hastie ND, Dempster M, Dunlop MG, et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-868.
12. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer Inst 1995;87:884-894.
13. Yazawa M, Okuda M, Setoguchi A, et al. Measurement of telomerase activity in dog tumors. J Vet Med Sci 1999;61:1125-1129.
14. Yazawa M, Okuda M, Setoguchi A, et al. Telomere length and telomerase activity in canine mammary gland tumors. Am J Vet Res 2001;62:1539-1543.
15. Funakoshi Y, Nakayama H, Uetsuka K, et al. Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol 2000;37:177-183.
16. Biller BJ, Kitchell BE, Cadile CD. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. Am J Vet Res 1998;59:1526-1529.
17. Long S, Argyle DJ, Nixon C, et al. Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours. Neuropathol Appl Neurobiol 2006;32:662-673.
18. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
19. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997;25:2595-2597.
20. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
21. Arai Y, Yajima T, Yagihashi A, et al. Limitations of urinary telomerase activity measurement in urothelial cancer. Clin Chim Acta 2000;296:35-44.
22. Bhuiyan J, Akhter J, O'Kane DJ. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder. Clin Chim Acta 2003;331:69-77.
23. Bialkowska-Hobrzanska H, Bowles L, Bukala B, et al. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol Diagn 2000;5:267-277.
24. Bian W, Xu Z. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. Int J Urol 2007;14:108-111.
25. Cheng CW, Chueh SC, Chern HD. Diagnosis of bladder cancer using telomerase activity in voiced urine. J Formos Med Assoc 2000;99:920-925.
26. Dalbagni G, Han W, Zhang ZF, et al. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Clin Cancer Res 1997;3:1593-1598.
27. Droller MJ, Kavaler E, Landman J, et al. Urinary telomerase and its possible role as a marker for bladder cancer. Keio J Med 1998;47:135-141.
28. Dettlaff-Pokora A, Matuszewski M, Schlichtholz B. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer. Cancer Lett 2005;222:83-88.
29. Fedriga R, Gunelli R, Nanni O, et al. Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine. Neoplasia 2001;3:446-450.
30. Gelmini S, Crisci A, Salvadori B, et al. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Clin Cancer Res 2000;6:2771-2776.
31. Kavaler E, Landman J, Chang Y, et al. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 1998;82:708-714.
32. Landman J, Chang Y, Kavaler E, et al. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer. Urology 1998;52:398-402.
33. Muller M, Krause H, Heicappell R, et al. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer. Clin Cancer Res 1998;4:1949-1954. (Pubitemid 28369180)
34. Morsi MI, Youssef AI, Hassouna ME, et al. Telomerase activity, cytokeratin 20 and cytokeratin 19 in the urine cells of bladder cancer patients. J Egypt Natl Canc Inst 2006;18:82-92.
35. Ramakumar S, Bhuiyan J, Besse J, et al. Comparison of screening methods in the detection of bladder cancer. J Urol 1999;161:388-394.
36. Rahat M, Lahat N, Gazawi H, et al. Telomerase activity in patients with transitional cell carcinoma: a preliminary study. Cancer 1999;85:919-924.
37. Sanchini MA, Gunelli R, Nanni O, et al. Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA 2005;294:2052-2056.
38. Siracusano S, Niccolini B, Knez R, et al. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine. Eur Urol 2005;47:327-333.
39. Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997;79:362-369. (Pubitemid 27029901)
40. Bassi P, De Marco V, De Lisa A, et al. Non-invasive diagnostic tests for bladder cancer: a review of the literature. Urol Int 2005;75:193-200.
41. Bennett A. Telomerase and other novel approaches to bladder cancer detection. Clin Lab Sci 2008;21:185-190.
42. Eissa S, Swellam M, Ali-Labib R, et al. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer. J Urol 2007;178:1068-1072.
43. Rozengurt N, Hyman WJ, Berry A, et al. Urinary cytology of a canine bladder carcinoma. J Comp Pathol 1986;96:581-585.
44. Mutsaers AJ, Widmer WR, Knapp DW. Canine transitional cell carcinoma. J Vet Intern Med 2003;17:136-144.
45. Knapp DW, Glickman NW, DeNicola DB, et al. Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Urol Oncol 2005;5:47-59.
46. n among vertebrates. Proc Natl Acad Sci U S A 1989;86:7049-7053.
47. Carioto LM, Kruth SA, Betts DH, et al. Telomerase activity in clinically normal dogs and dogs with malignant lymphoma. Am J Vet Res 2001;62:1442-1446.
48. Vrooman OPJ, Witjes JA. Molecular markers for detection, surveillance, and prognostication of bladder cancer. Int J Urol 2009;16:234-243.
49. Sanchini MA, Bravaccini S, Medri L, et al. Urine telomerase: an important marker in the diagnosis of bladder cancer. Neoplasia 2004;6:234-239.
50. Wang Z, Ramin SA, Tsai C, et al. Evaluation of PCR-ELISA for determination of telomerase activity in prostate needle biopsy and prostatic fluid specimens. Urol Oncol 2002;7:199-205.